Core Viewpoint - Sportstech Brands Holding GmbH disputes claims made by Interactive Strength Inc. regarding legal obligations and asserts that these claims are factually and legally incorrect [1][2][3] Legal Position - Sportstech has conducted a comprehensive legal review and believes that the loan agreements from January 27, 2025, and May 22, 2025, are void under German law [2][4] - The company has initiated legal steps to clarify its position under German law and has not been served with any lawsuits from TRNR in Germany [3][4] Claims and Negotiations - Sportstech denies the existence of the claims asserted by TRNR in the amounts alleged and maintains that any documents related to a potential acquisition were not binding [5][6] - The company is open to constructive discussions with TRNR regarding any legally valid obligations and is willing to negotiate a settlement [7][9] Operational Status - Despite the ongoing legal dispute, Sportstech continues its business operations without restrictions and is pursuing its strategic growth trajectory [9][10] - The company is confident that an agreement will be reached, albeit for a significantly lower amount than previously claimed [9] Market Position - Sportstech Brands Holding GmbH is recognized as an internationally active company in the home fitness, wellness, and lifestyle products sector, holding a strong market position in Europe [11]

TOKYO, Jan. 23, 2026 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo; President and CEO: Kouji Eguchi; listed on Nasdaq: NASDAQ: MRM, hereinafter “MEDIROM”), a company engaged in diversified healthcare businesses, has entered into a Master Service Agreement (the “MSA”) with Tools for Humanity (“TFH”) and the World Foundation (“WF”), and will support World ID adoption with the installation of Orbs across 3,000 locations nationwide in Japan. Tools for Humanity was co- ...

Investment Rating - The report indicates a positive outlook for the AI-driven wellness industry, emphasizing that AI is becoming the core operating layer rather than an add-on feature [6][15]. Core Insights - The wellness industry is transitioning to adaptive systems that leverage AI to enhance user engagement and outcomes, driven by advancements in behavioral and biometric modeling, multi-step orchestration, and real-time computing [3][6]. - By 2026, over 60% of digital wellness interactions will be managed by AI systems, significantly improving engagement and retention metrics [8][15]. - The focus is shifting from mere engagement metrics to measurable health outcomes, with platforms competing on improvements in fitness, sleep, and metabolic health [11][12]. Summary by Sections Executive Summary - AI is central to transforming wellness platforms from episodic experiences to adaptive systems that respond in real-time [3][4]. Key Signals - AI will drive over 60% of digital wellness interactions by 2026, with personalized onboarding increasing early engagement by 22-40% [8]. Predictions for 2026 - Agentic wellness copilots will manage most member interactions, allowing human coaches to focus on complex cases [9][10]. - Wellness brands will prioritize measurable outcomes over engagement metrics [11]. - Hyper-personalized, self-tuning programs will become the standard expectation for users [13][14]. Technology Foundations - The report outlines a five-layer AI stack that enables continuous adaptation in wellness platforms, moving beyond static programs [68]. - Multi-agent orchestration systems will coordinate various AI agents across the member journey, enhancing personalization and effectiveness [69]. ROI Mandate - The performance of AI-driven wellness systems will be evaluated based on measurable, repeatable outcomes, focusing on activation, retention, and operational efficiency [86][90]. - Illustrative performance metrics indicate significant improvements in engagement and retention rates due to AI orchestration [91][97]. What's Next: 2027-2028 Outlook - Future wellness platforms will evolve into systems that continuously adapt to user behavior, integrating predictive modeling and preventive wellness strategies [101][109].

Core Viewpoint - Unilever PLC (NYSE:UL) is facing challenges in its stock performance and market confidence, with recent downgrades from analysts indicating concerns over valuation and earnings growth potential [2][3]. Group 1: Analyst Ratings and Price Targets - BNP Paribas downgraded Unilever PLC from Outperform to Neutral with a price target of $71, citing that valuations in the consumer staples sector are expected to remain "cheap" [2]. - Jefferies maintained an Underperform rating but raised its price target for Unilever from 4,000 GBp to 4,100 GBp, highlighting challenges in price and operating margins that limit earnings growth [2]. Group 2: Financial Performance and Market Concerns - Unilever's stock is down by 1.65% year-to-date as of January 9, 2026, indicating a negative market sentiment [3]. - Jefferies noted that volume and mix are expected to be approximately 2% in the fourth-quarter results, with concerns about declining U.S. growth contributions affecting market confidence in the first half of 2026 [2].

Financial Data and Key Metrics Changes - The company reported a record Q2 net revenue of $218 million, with an adjusted EBITDA of $8.4 million and a reported EPS loss of $0.02, reflecting a significant improvement in performance metrics [4][22]. - The net loss for the quarter was $43.5 million, a 49% improvement year-over-year compared to $85.3 million, with cash flow used in operations reduced to $8.5 million from $40.7 million last year [26][27]. Business Line Data and Key Metrics Changes - Cannabis net revenue increased to $67.5 million, driven by a 36% increase in international cannabis revenue and a 6% increase in Canadian adult-use cannabis [22][23]. - Beverage revenue totaled $50.1 million, impacted by headwinds in the craft beer segment, while distribution revenue grew by 26% year-over-year to $85.3 million [11][23]. - Wellness revenue remained flat year-over-year at $14.6 million, with challenges in the club retail channel being addressed [24]. Market Data and Key Metrics Changes - The international cannabis business saw a 51% sequential growth, reaching $20 million, marking one of the strongest quarters to date despite ongoing regulatory challenges [9][10]. - In Canada, the adult-use medical sales channel net of excise tax grew to $46 million, with recreational cannabis sales increasing by 6% [12][22]. Company Strategy and Development Direction - The company aims to leverage its strong balance sheet and cash position to capitalize on strategic opportunities in a rapidly evolving regulatory environment, particularly in the U.S. cannabis market [5][28]. - Tilray is focused on expanding its pharmacy reach in Germany and tripling its medical cannabis distribution footprint in fiscal 2026 [10][11]. - The company emphasizes the importance of modernizing Canadian cannabis regulations to maintain its competitive edge in the global market [14][15]. Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's trajectory for the second half of fiscal 2026 and beyond, citing a diversified platform and improving fundamentals [21][28]. - The company is prepared for potential regulatory changes in the U.S. and anticipates that cannabis rescheduling will lead to a federally compliant medical cannabis framework [7][8]. Other Important Information - The company operates more than 40 brands in over 20 countries and is a leader in various segments, including cannabis, craft beer, and wellness products [5][6]. - The company has a strong cash position of approximately $292 million, providing flexibility for strategic investments [5][27]. Q&A Session Summary Question: What can the industry do to improve the regulatory outcome regarding the intoxicating hemp ban? - Management is working with legislators to extend the deadline or modify regulations to allow for a regulated amount of milligrams to be sold nationally [33][34]. Question: Can you quantify how much supply was held back from the Canadian market? - Approximately $5 million worth of supply was held back, which will be redeployed into higher-margin international markets [37][38]. Question: How much of the Canadian adult-use cannabis growth was volume versus price mix? - The growth was primarily driven by demand and new distribution, with a slight market share gain despite challenges [45][46]. Question: What are the expectations for growth within the Canadian market? - Management anticipates mid- to high single-digit growth, focusing on premium products and new product launches [57][58]. Question: Can you provide more color on the CC Pharma business and its distribution reach? - The company aims to triple its distribution reach and is focused on leveraging its sales organization to sell more medical cannabis in Germany [67][68].

Core Insights - Tilray Brands, Inc. reported a record net revenue of $218 million for the second fiscal quarter ended November 30, 2025, reflecting a 3% increase compared to the previous year [3][5] - The company is well-positioned for growth in the U.S. medical cannabis market, anticipating federal rescheduling to enhance research and patient access [3][5] - Tilray's financial position remains strong with $292 million in cash and marketable securities, and a net cash position of approximately $30 million [2][4][6] Financial Performance - Net revenue increased by 3% to $217.5 million from $211.0 million year-over-year [5][28] - Cannabis net revenue rose by 3% to $67.5 million, driven by a 36% increase in international cannabis revenue and a 6% increase in Canadian adult-use cannabis [5][32] - Gross profit decreased to $57.5 million from $61.2 million, with a gross margin of 26% compared to 29% in the prior year [5][28] Segment Performance - Beverage net revenue was $50.1 million, down from $63.1 million, with a gross margin of 31% compared to 40% [5][32] - Distribution net revenue reached a record $85.3 million, up from $67.6 million, with a gross margin of 13% [5][32] - Wellness segment revenue remained flat at $14.6 million, with a slight increase in gross profit [5][32] Loss and Adjustments - The net loss improved to $(43.5) million from $(85.3) million, with net loss per share improving to $(0.41) from $(0.99) [5][28] - Adjusted EBITDA was $8.4 million, slightly down from $9.0 million [5][28] - Adjusted net loss and adjusted net loss per share improved to $(2.0) million and $(0.02), respectively [5][28] Cash Flow and Balance Sheet - Cash used in operations improved by $32.2 million to $(8.5) million from $(40.7) million [4][30] - The cash and marketable securities balance grew to $291.6 million, providing flexibility for strategic opportunities [4][6] - Total outstanding debt was reduced by $4.2 million, strengthening the balance sheet [4][6]

Core Insights - Tilray Brands, Inc. is a significant player in the cannabis industry, involved in research, cultivation, production, marketing, and distribution of medical cannabis products [1] - The company operates across multiple segments, including Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business, catering to a diverse customer base [1] Price Target and Analyst Sentiment - The consensus price target for Tilray has increased from $4.5 to $10 over the past year, indicating growing optimism among analysts [2] - Analyst John Zamparo from CIBC has set a more conservative price target of $8, reflecting a cautious approach ahead of the company's second-quarter earnings results scheduled for January 8, 2025 [2] Strategic Expansions and Stock Performance - Tilray's strategic expansions and partnerships in the beverage alcohol and wellness sectors have positively influenced stock sentiment [3] - The company's stock value has nearly tripled over the past six months, driven by the anticipation of cannabis reclassification in the United States, which is expected to significantly benefit cannabis growers like Tilray [3] Financial Performance - Recent earnings reports have shown improvements in revenue and profitability, supported by strong sales in both the cannabis and beverage alcohol segments [4] - The financial strength of Tilray is crucial as the cannabis industry continues to grow, driven by increasing consumer demand and the adoption of medical cannabis [4] Product Innovation - Product innovation is a key focus for Tilray, with new offerings such as GMP-certified flowers, oils, vapes, edibles, and topicals [5] - These innovations help Tilray maintain its competitive edge and attract a broader customer base in the evolving cannabis industry [5]

Core Insights - Tilray Brands, Inc. is redefining mindful drinking with a new collection that includes hemp-derived delta-9 THC cocktails, zero-proof spirits, and non-alcoholic beers, aiming to make moderation feel indulgent rather than limiting [1][4] - The sober curious movement is driving consumer demand for flavorful and sophisticated drinks, and Tilray's Dry January lineup is positioned to meet this demand with innovative offerings [2][4] Company Overview - Tilray Brands, Inc. is a leading global lifestyle and consumer packaged goods company with operations in multiple regions including Canada, the United States, Europe, Australia, and Latin America, focusing on cannabis, beverage, wellness, and entertainment [5] - The company supports over 40 brands in more than 20 countries, offering a diverse range of products including cannabis offerings, hemp-based foods, and craft beverages [5] Market Trends - Non-alcoholic beer sales increased by over 20% last year, indicating a growing trend towards mindful drinking, with THC-infused beverages also gaining popularity as functional alternatives [4] - The Dry January initiative is not just a seasonal trend but reflects a broader shift in consumer preferences towards healthier drinking options [4] Product Offerings - The Dry January Collection includes: - Happy Flower: Sparkling THC cocktails infused with hemp-derived Delta-9 THC [8] - Fizzy Jane's: THC seltzers with refreshing flavors [8] - Mock One: Premium zero-proof spirits designed to replicate traditional spirits [8] - Runner's High: Non-alcoholic beer for active lifestyles [8] - Montauk Brewing: Non-alcoholic craft brews including N.A IPA and N.A. Golden [8] - 10 Barrel Brewing: NA Apocalypse IPA, a non-alcoholic version of their original IPA [8]

Core Viewpoint - Tilray Brands, Inc. will announce its financial results for the second quarter of fiscal year 2026 on January 8, 2026, after market close [1] Group 1: Financial Results Announcement - The financial results will cover the period ending November 30, 2025 [1] - A live conference call and audio webcast will be held on the same day at 4:30 PM Eastern Time to discuss these results [2] - Investors can submit questions via Robinhood and Say Technologies until January 7, 2026 [2] Group 2: Company Overview - Tilray is a leading global lifestyle and consumer packaged goods company with operations in multiple regions including Canada, the United States, Europe, Australia, and Latin America [3] - The company focuses on cannabis, beverage, wellness, and entertainment sectors, aiming to elevate lives through moments of connection [3] - Tilray supports over 40 brands in more than 20 countries, offering a range of products including cannabis, hemp-based foods, and craft beverages [3]

Core Viewpoint - Tilray Brands, Inc. is set to release its financial results for the second fiscal quarter ending November 30, 2025, on January 8, 2026, after market close [1] Group 1: Financial Results Announcement - The financial results will be announced after the financial markets close on January 8, 2026 [1] - A live conference call and audio webcast will be held at 4:30 PM Eastern Time on the same day to discuss these results [2] Group 2: Investor Engagement - Investors can submit and upvote questions via Robinhood and Say Technologies from now until January 7, 2026 [3] - Questions can be submitted on the Tilray stock detail page on Robinhood or through the Say Technologies platform [3] Group 3: Company Overview - Tilray is a leading global lifestyle and consumer packaged goods company with operations in multiple regions including Canada, the United States, Europe, Australia, and Latin America [3] - The company focuses on cannabis, beverage, wellness, and entertainment sectors, aiming to elevate lives through moments of connection [3] - Tilray supports over 40 brands in more than 20 countries, offering a range of products including cannabis offerings, hemp-based foods, and craft beverages [3]